Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Zoono Group Limited ( (AU:ZNO) ) is now available.
Zoono Group Limited reported a 19.1% increase in revenue to NZ$1,250,133 for the year ending June 2025, while significantly reducing its net loss by 59% to NZ$3,766,769. Despite the improved financial performance, the company decided not to pay a dividend for the year, indicating a cautious approach as it continues to stabilize its operations and strengthen its market position.
More about Zoono Group Limited
Zoono Group Limited operates in the biotechnology industry, focusing on the development and distribution of antimicrobial solutions. Their primary products are aimed at providing long-lasting protection against germs and pathogens, with a market focus on health and hygiene sectors.
Average Trading Volume: 343,453
Technical Sentiment Signal: Sell
Current Market Cap: A$12.47M
Find detailed analytics on ZNO stock on TipRanks’ Stock Analysis page.